…….. is available at Jill Stanek’s blog.
After years of planned parenthood pushing the morning after pill, they have turned on Plan B One-step, admitting what Pharmer has been saying for years, that it’s very ineffective.
What Jill Stanek points out is that Planned Parenthood already had a campaign lined up to push Ella (ulipristal acetate) analog of the mifepristone abortion pill, as the new morning after pill, and an IUD, which could bring them even more cash than their abortion procedures do. This campaign was already in the pipeline BEFORE Mother Jones spilled the story of Plan B’s ineffectiveness to the low information crowd. Note that the video linked above was already uploaded on September 3, 2013, prior to the Mother Jones publication. Anne Glasier’s study of Plan B inefficacy in women was published in 2011.
Back in 2010, Pharmer brought to your attention the CHMP assessment report, filed by the manufacturer of Ella One to Europe’s version of the FDA. and explained some of the features of the pill. Initially mentioned was that Ella One, which is called Ella in the U.S. is not very effective, and that the embryocidal dose of the pill is lower than the dose required to stop ovulation, demonstrated in the animal trials. Also from this report, is the information that the 30mg dose is designed for 60 kg (132 lb) women, is designed to deliver the 0.5mg/kg dose which the manufacturer stated to be insufficient to stop ovulation, but effective against pregnancy. This dose is not sufficient for larger women, and so Ella has similar efficacy problems as the various forms of Plan B and Plan B One-Step (levonorgestrel).
Expect planned parenthood to sell Ella as long as it can get away with it, then kick the morning after use aside, as women are persuaded to wear the indwelling coat hanger, Para-Gard, a copper IUD. Pharmer thinks that planned parenthood will always keep Ella around generically, since it can be substituted for the mifepristone now marketed in the U.S. for chemical abortions.